Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nerve Sheath Tumor”

485 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 485 results

Testing effectiveness (Phase 2)Ended earlyNCT03095248
What this trial is testing

Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

Who this might be right for
Neurofibromatosis 2Vestibular SchwannomaMeningioma+2 more
Children's Hospital Medical Center, Cincinnati 10
Not applicableNot Yet RecruitingNCT03359304
What this trial is testing

The Neurofibromatosis-associated Tumor Biobank

Who this might be right for
Neurofibromatoses
Ren tingting 300
Large-scale testing (Phase 3)Ended earlyNCT01189253
What this trial is testing

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 133
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Testing effectiveness (Phase 2)Study completedNCT01412892
What this trial is testing

Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromaNeurofibromatoses
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Study completedNCT01207687
What this trial is testing

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
National Cancer Institute (NCI) 14
Very early researchLooking for participantsNCT06693284
What this trial is testing

A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]

Who this might be right for
Primary Malignant Peripheral Nerve Sheath Tumors
University of Minnesota 8
Testing effectiveness (Phase 2)Looking for participantsNCT05642455
What this trial is testing

SPEARHEAD-3 Pediatric Study

Who this might be right for
Synovial SarcomaMalignant Peripheral Nerve Sheath Tumor (MPNST)Neuroblastoma (NBL)+1 more
USWM CT, LLC 20
Not applicableStudy completedNCT04474678
What this trial is testing

Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")

Who this might be right for
Brain TumorNeurofibromatosesSarcoma+3 more
Medical University of Vienna 240
Testing effectiveness (Phase 2)Study completedNCT02839720
What this trial is testing

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis Type 1Optic Nerve Glioma
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)Study completedNCT02831257
What this trial is testing

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

Who this might be right for
Neurofibromatosis 2Meningioma
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Study completedNCT01767792
What this trial is testing

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Who this might be right for
Neurofibromatosis Type 2Progressive Vestibular Schwannomas
University of Alabama at Birmingham 22
Not applicableActive Not RecruitingNCT03346889
What this trial is testing

Vestibular Outcomes in Vestibular Schwannoma

Who this might be right for
Vestibular Schwannoma
Haukeland University Hospital 155
Testing effectiveness (Phase 2)UnknownNCT03393689
What this trial is testing

RGD PET/MRI in Sporadic Vestibular Schwannoma

Who this might be right for
Acoustic Neuroma
Rigshospitalet, Denmark 40
Not applicableUnknownNCT04417868
What this trial is testing

Evolution of Cochleovestibular Schwannomas

Who this might be right for
Schwannoma
University Hospital, Strasbourg, France 140
Not applicableUnknownNCT04712214
What this trial is testing

Use of Non-invasive Optical Analysis in Neurosurgery

Who this might be right for
Brain TumourGliomaMeningioma+2 more
Imperial College London 50
Not applicableLooking for participantsNCT06360406
What this trial is testing

Real-World Treatment Study of Koselugo (Selumetinib)

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
AstraZeneca 200
Large-scale testing (Phase 3)Ended earlyNCT04461886
What this trial is testing

A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I

Who this might be right for
Neurofibromatosis
Nobelpharma 100
Not applicableUnknownNCT02680431
What this trial is testing

Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
Juha Peltonen 100
Load More Results